NCT00510926View on ClinicalTrials.gov

Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

November 30, 2006

Conditions
Myeloid Leukemia, Chronic, Chronic-Phase
Interventions
DRUG

Imatinib Mesilate (Glivec)

Trial Locations (1)

40138

"Policlinico S.Orsola-Malpighi, Istituto di Ematologia e Oncologia Medica L. e A. Seràgnoli", Bologna

All Listed Sponsors
lead

University of Bologna

OTHER

NCT00510926 - Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase | Biotech Hunter | Biotech Hunter